Client News

Greenlane (Nasdaq:GNLN) Selects Mainstem’s B2B Procurement Platform to Compliment its Supply Chain Ecosystem

Platform designed to enhance new customer access, supply chain coordination, inventory management, and purchasing MSO’s can create their own catalog of Greenlane products, enhancing customer loyalty and ease of reordering BOCA RATON, FL / ACCESS Newswire / March 25, 2025 / Greenlane Holdings, Inc. (“Greenlane” or the “Company”) (Nasdaq:GNLN), one of the premier global sellers of premium cannabis […]

Innovation Beverage Group’s (Nasdaq:IBG) Bitters Captures 45% Market Share in Australia Driven by 2024 Sales Growth

Australia is the world’s second largest bitters market, behind only the U.S. SEVEN HILLS, AU / ACCESS Newswire / March 25, 2025 / Innovation Beverage Group Ltd, (“IBG” or the “Company”) (Nasdaq:IBG), an innovative developer, manufacturer, and marketer of a growing beverage portfolio of 60 formulations across 13 alcoholic and non-alcoholic brands, announced today that sales of its Australian […]

Inspire Veterinary Partners (NASDAQ:IVP) Announces up to $6.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

VIRGINIA BEACH, VA / ACCESS Newswire / March 25, 2025 / Inspire Veterinary Partners, Inc. (NASDAQ:IVP) (“Inspire” or the “Company”), an owner and provider of pet health care services throughout the U.S.,today announced it has entered into a securities purchase agreement with an investor to purchase 1,092,896 shares of its common stock (or a pre-funded warrant in lieu […]

Greenlane (Nasdaq:GNLN) Reports Fourth Quarter and Full Year 2024 Financial Results

BOCA RATON, FL / ACCESS Newswire / March 21, 2025 / Greenlane Holdings, Inc. (“Greenlane” or the “Company”) (Nasdaq:GNLN), one of the premier global sellers of premium cannabis accessories, child-resistant packaging, and specialty vaporization products, today reported its financial results for the fourth quarter and twelve months ended December 31, 2024, and the filing of an annual report […]

Aspire Biopharma Holdings, Inc., (NASDAQ:ASBP) Contract Manufacturer, Glatt Air Techniques, Inc., has Completed Its First Good Manufacturing Practice (“GMP”) Clinical Batch of Pharmaceutical Grade Oral Mucosal Fast Acting Formulation of Aspirin

Subsequent phase involves completion of chemistry, manufacturing, and controls (CMC) testing for data to support FDA submission Company expects to commence bioavailability study in April 2025 Aspire intends to request “fast track” approval on FDA application for its high dose aspirin product HUMACAO, PR AND NEW YORK, NY / ACCESS Newswire / March 20, 2025 / Aspire Biopharma […]

Interactive Strength Inc. (Nasdaq:TRNR) Issues Shareholder Update on Positive Developments

Company Executes Against M&A Plan, Reiterates $50M+ Pro Forma Guidance, Additional $15M+ Revenue Deal that is expected to increase guidance; Institutional Investor Backing, Exclusive Distribution Agreements & Repeat Sales AUSTIN, TX / ACCESS Newswire / March 19, 2025 / Interactive Strength Inc. (NASDAQ:TRNR) (“TRNR” or the “Company”), maker of innovative specialty fitness equipment under the CLMBR and FORME […]

SBC Medical Group (NASDAQ: SBC) to Announce Full Year 2024 Financial Results on March 28, 2025

TOKYO, March 18, 2025–(BUSINESS WIRE)–SBC Medical Group Holdings Incorporated (NASDAQ: SBC, “SBC Medical”, or the “Company”), a global owner, operator and provider of management services and products to cosmetic treatment centers, today announced that it will report its full year 2024 financial results before the U.S. market open on Friday, March 28, 2025. The Company […]

Inspire Veterinary Partners (Nasdaq:IVP) Signs Exclusive Non-Binding Letter of Intent to Acquire Central Florida Based Animal Hospital

Proposed acquisition could potentially add approximately $1.8 million (unaudited) revenue, increase Inspire’s current locations in Florida to 5, and bring the total number of animal hospitals in its network to 14. VIRGINIA BEACH, VA / ACCESS Newswire / March 17, 2025 / Inspire Veterinary Partners, Inc. (Nasdaq:IVP) (“Inspire” or the “Company”), an owner and provider of pet health […]

Aspire Biopharma Holdings, Inc., (NASDAQ:ASBP) Provides Update on Recently Filed U.S. Patent Applications for Its Sublingual Drug Delivery Platform

HUMACAO, PUERTO RICO AND NEW YORK, NY / ACCESS Newswire / March 13, 2025 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) (“Aspire” or the “Company”), a developer of a multi-faceted patent-pending drug delivery technology, today provided an update on its two patent applications, originally filed as provisional patent applications with the U.S. Patent and Trademark Office (“USPTO”) on March […]

Start Expanding
Your Shareholder Base

Let us help you connect with investors
committed to your success.